Expand AXNX Menu
AXNX MENU

AXNX Stock Summary and Trading Ideas (Axonics | NASDAQ:AXNX)

Charts for Today's Stock Price and Implied Volatility in Axonics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AXNX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Axonics (AXNX) Frequently Asked Questions

What does Axonics do?

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

What symbol and exchange does Axonics stock trade?

Axonics trades on the NASDAQ stock market under the symbol AXNX.

What is Axonics stock price doing today?

As of April 23, 2024, AXNX stock price declined to $66.56 with 240,234 million shares trading.

What is Axonics's Beta?

AXNX has a beta of 1.43, meaning it tends to be more sensitive to market movements. AXNX has a correlation of 0.20 to the broad based SPY ETF.

How much is Axonics worth?

AXNX has a market cap of $3.39 billion. This is considered a Mid Cap stock.

How much money does Axonics make?

Last quarter Axonics reported $110 million in Revenue and $.13 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.07.

What is the highest and lowest price Axonics traded in the last 3 year period?

In the last 3 years, AXNX stock traded as high as $79.92 and as low as $38.41.

What are the top ETFs holding Axonics?

The top ETF exchange traded funds that AXNX belongs to (by Net Assets): VTI, VB, IWM, VXF, VBK.

Is Axonics (AXNX) a good investment?

AXNX has underperformed the market in the last year with a return of +10.5%, while the SPY ETF gained +24.0%. In the last 3 month period, AXNX fell short of the market, returning -2.1%, while SPY returned +4.7%. However, in the most recent 2 weeks AXNX has outperformed the stock market by returning -1.7%, while SPY returned -2.8%.

What is the support and resistance for Axonics (AXNX) stock price?

AXNX support price is $66.36 and resistance is $67.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AXNX stock will trade within this expected range on the day.